Recent studies indicate that the methylation state of histones can be dynamically regulated by histone methyltransferases and demethylases 1, 2 . The H3K9-specific demethylase Jhdm2a (also known as Jmjd1a and Kdm3a) has an important role in nuclear hormone receptor-mediated gene activation and male germ cell development 3, 4 . Through disruption of the Jhdm2a gene in mice, here we demonstrate that Jhdm2a is critically important in regulating the expression of metabolic genes. The loss of Jhdm2a function results in obesity and hyperlipidemia in mice. We provide evidence that the loss of Jhdm2a function disrupts b-adrenergic-stimulated glycerol release and oxygen consumption in brown fat, and decreases fat oxidation and glycerol release in skeletal muscles. We show that Jhdm2a expression is induced by b-adrenergic stimulation, and that Jhdm2a directly regulates peroxisome proliferator-activated receptor a (Ppara) and Ucp1 expression. Furthermore, we demonstrate that b-adrenergic activation-induced binding of Jhdm2a to the PPAR responsive element (PPRE) of the Ucp1 gene not only decreases levels of H3K9me2 (dimethylation of lysine 9 of histone H3) at the PPRE, but also facilitates the recruitment of Pparc and Rxra and their co-activators Pgc1a (also known as Ppargc1a), CBP/ p300 (Crebbp) and Src1 (Ncoa1) to the PPRE. Our studies thus demonstrate an essential role for Jhdm2a in regulating metabolic gene expression and normal weight control in mice.
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Using a hypomorphic Jhdm2a knockout model, we have previously shown an important role for the H3K9 demethylase Jhdm2a in spermatogenesis 3 . To further characterize the biological function of this demethylase, we created a new mouse line with the catalytic jumonji C domain floxed by loxP sites (Supplementary Fig. 1a ). Heterozygous mice were generated by crossing 3lox mice with EIIa-Cre transgenic mice ( Supplementary Fig. 1a, b) . Jhdm2a 1lox/1lox (knockout) mice were obtained by intercrossing Jhdm2a 1lox/1 mice, and were confirmed by PCR and western blot analysis ( Supplementary Fig. 1b, c) . Similar to the hypomorphic Jhdm2a mice, the complete knockout mice exhibit spermatogenesis defects (data not shown). Interestingly, the Jhdm2a knockout mice become obese in adulthood when compared to their wild-type littermates ( Fig. 1a and Supplementary Fig. 2 ). The obese phenotype is also observed in Jhdm2a knockout mice backcrossed onto a C57BL/6 background (data not shown), as well as in the hypomorphic Jhdm2a mice on a mixed 129SV/Ola and C57BL/6 background ( Supplementary Fig. 3 ), indicating that Jhdm2a deficiency leads to obesity irrespective of the genetic background. Consistent with a potential role for Jhdm2a in energy homeostasis, Jhdm2a is expressed at a relatively higher level in organs responsive to sympathetic nerve activity, such as brown adipose tissue (BAT) and skeletal muscle ( Supplementary Fig. 4 ). In contrast, Jhdm2a expression in brain is almost undetectable (Supplementary Fig. 4 ).
Magnetic resonance imaging (MRI) analysis revealed marked body fat deposition in 4-month-old knockout mice ( Supplementary   Fig. 2c ). However, non-adipose tissues (lean) were comparable between wild-type and Jhdm2a knockout mice ( Supplementary  Fig. 2c ). Similar to that observed in human obesity, large fat droplets are observed in white adipose tissue, as well as in muscle and liver (Fig. 1b) . In addition, serum lipid content-including free fatty acid, triglyceride and total cholesterol-is significantly higher in the knockout mice (Fig. 1c) . Furthermore, a high-fat diet accelerated the onset of obesity in the knockout mice (Fig. 1d) . Collectively, these findings suggest that the loss of Jhdm2a function results in abnormal fat metabolism and obesity.
The body weight of an animal is maintained through a balance between food intake and energy expenditure 5, 6 . To understand how Jhdm2a deficiency results in obesity, we first analysed food intake before the onset of obesity using 6-week-old mice, and found that caloric intake is not increased in the Jhdm2a knockout mice (Supplementary Fig. 5a ). Similarly, the 16-week-old Jhdm2a knockout mice did not show an increased food intake, regardless of the fat content present in the diet (Supplementary Fig. 5b ). In addition, the serum leptin level is not significantly altered in 6-week-old Jhdm2a knockout mice before they become obese ( Supplementary Fig. 5c ).
Given that the human counterpart of mouse Jhdm2a has been previously demonstrated to function as a transcriptional co-activator 4 , we compared the gene expression profiles of wild-type and Jhdm2a knockout skeletal muscles using Affymetrix microarray technology. We chose to perform the analysis in skeletal muscle because of the high expression of Jhdm2a and also its role in energy expenditure. Of the 43,000 probes analysed, 602 probes (1.4%) were downregulated at least twofold and 220 probes (0.05%) were upregulated at least twofold in Jhdm2a knockout soleus muscle. Gene ontology enrichment analysis indicated that the largest proportion of downregulated genes were involved in metabolic processes (P 5 0.03) ( Supplementary Fig. 6a ), whereas genes involved in lipid metabolism were the most enriched (P , 1 3 10 24 ) ( Supplementary Fig. 6b-e) . Interestingly, pathway analysis showed that a significant proportion of the genes involved in PPAR signalling are downregulated in response to the Jhdm2a knockout (P , 1 3 10 211 ) ( Supplementary Fig. 7 ). Quantitative PCR with reverse transcription (qRT-PCR) confirmed the downregulation of many genes involved in the PPAR pathway, including Ppara, Ucp2, MCAD (also known as Acadm), LCAD (Acadl), VLCAD (Acadvl) and Aqp7 but not Ppard (Fig. 2a) . Consistent with the fact that multiple rate-limiting enzymes for fatty acid oxidation, such as MCAD, LCAD and VLCAD, were downregulated in the Jhdm2a knockout skeletal muscle, b-oxidation of palmitic acid was significantly decreased in primary myocytes derived from the Jhdm2a knockout newborn (Fig. 2b) . Consistent with downregulation of Aqp7 (Fig. 2a) , glycerol release in response to a b-adrenergic agonist is impaired in the Jhdm2a knockout soleus muscle (Fig. 2c) . These results are consistent with previous demonstrations that Ppara has an essential involvement in fatty acid metabolism [7] [8] [9] . Notably, the results also indicate that the impaired expression of Ppara and its downstream target genes might be one of the causes of abnormal fat accumulation in the Jhdm2a knockout mice, because previous studies have shown that Pparadeficient mice are prone to diet-induced obesity 9 and that Aqp7 deficiency causes obesity in adult mice 10 .
To understand how the loss of Jhdm2a function results in the downregulation of Ppara and its target genes, we analysed the presence of Jhdm2a around defined PPRE sequences using chromatin immunoprecipitation (ChIP) [11] [12] [13] [14] . Results indicate that Jhdm2a binds to the PPRE of Ppara, but not to the PPREs of MCAD, Acox1 or Scp2 (Fig. 2d) . Consistent with the function of Jhdm2a as an H3K9me2 demethylase, the level of H3K9me2 at the region encompassing the PPRE of the Ppara gene is significantly increased in the Jhdm2a knockout muscle cells (Fig. 2e) . To demonstrate that the reduced Ppara expression in Jhdm2a knockout muscle cells is a cell-intrinsic effect, we performed qRT-PCR and ChIP analysis using in vitro cultured primary myocytes derived from newborn wild-type and knockout mice. Results shown in Fig. 2f demonstrate that Ppara is decreased by 50% in Jhdm2a knockout myocytes. ChIP analysis showed increased levels of H3K9me2 at the Ppara PPRE of Jhdm2a knockout myocytes (Fig. 2g) . Notably, both Ppara expression and promoter H3K9me2 levels at PPRE can be partially rescued by overexpression of human JHDM2A (Fig. 2f, g ). These data collectively support the notion that Ppara is a direct target of Jhdm2a and that Jhdm2a plays an important part in lipid metabolism in skeletal muscle cells.
In addition to skeletal muscle, Jhdm2a is also highly expressed in BAT ( Supplementary Fig. 4 ). Jhdm2a deficiency resulted in the enlargement and accumulation of lipid droplets in the BAT (Supplementary Fig. 8) . Consistent with the BAT abnormities, Jhdm2a knockout mice showed defective adaptive thermogenesis (Fig. 3a) . The phenotypic similarity between Jhdm2a knockout mice and mice lacking b-adrenergic receptors 15 raises the possibility that Jhdm2a might be a critical factor in b-adrenergic signalling. Consistent with this notion, b-adrenergic-stimulated oxygen consumption and glycerol release are greatly reduced in the Jhdm2a knockout BAT (Fig. 3b, c) . In addition, genes involved in mitochondrial functions including Ppara, Ucp3, Cpt2 and LCAD are also decreased in the Jhdm2a knockout BAT (Fig. 3d) . Furthermore, analysis of the expression of Ucp1 and Dio2, two key genes involved in thermogenesis in BAT 16 , demonstrated that cold-induced Ucp1 upregulation is almost completely blocked although Dio2 induction is not affected (Fig. 3e) . Given the critical function of Ucp1 in cold sensitivity 17 , defective activation of Ucp1 by b-adrenergic signalling is probably one contributing factor of defective thermogenesis in the Jhdm2a knockout BAT.
As one of the most important molecules involved in cold-induced thermogenesis in brown fat, the transcriptional regulation of Ucp1 has been extensively characterized 16 . In addition to Ppara and Pparc, other transcription factors and co-activators known to be involved in Ucp1 activation include Rxra, Atf2, p300, Src1 and Pgc1a. qRT-PCR demonstrates that the expression of these genes is not significantly altered in the Jhdm2a knockout BAT (Supplementary Fig. 9 ), however cold-induced upregulation of Ppara is defective in knockout BAT (Supplementary Fig. 9 ). This indicates that the defect in coldinduced Ucp1 induction in Jhdm2a knockout BAT might be mediated through Ppara, which is a direct target of Jhdm2a in muscle cells (Fig. 2d) . Given that cold-induced Ucp1 upregulation is intact in the Ppara deficient mice 18 , we explored the possibility that Jhdm2a directly regulates Ucp1 expression in response to cold exposure.
To ascertain that the effect of Jhdm2a on Ucp1 expression is cell intrinsic, we performed short-hairpin RNA (shRNA)-mediated Jhdm2a knockdown in the brown adipose cell line HIB1B using lentivirus-based shRNA. Although Jhdm2a knockdown does not affect HIB1B differentiation (data not shown), the differentiated knockdown cells have impaired Ucp1 activation by isoproterenol (ISO), a general b-adrenergic receptor agonist (Fig. 4a) , consistent with the result obtained in Jhdm2a knockout BAT (Fig. 3e) . Importantly, enforced overexpression of human JHDM2A in the knockdown cells partially rescued Ucp1 expression (Fig. 4b) . Interestingly, both the messenger RNA and protein levels of Jhdm2a are upregulated in response to b-adrenergic receptor activation (Fig. 4c) , supporting Jhdm2a as an integral component of the b-adrenergic signalling pathway. Similar to that observed in mouse brown fat tissues, the expression of the transcription factors and coactivators involved in Ucp1 activation is not significantly altered in the HIB1B knockdown cells (Supplementary Fig. 10a ). ISO-induced upregulation of Pgc1a is also maintained in HIB1B knockdown cells ( Supplementary Fig. 10a ). We next explored the possibility that Jhdm2a directly regulates Ucp1 expression. ChIP analysis demonstrated that Jhdm2a can bind to the Ucp1 enhancer region 19 in a b-adrenergic receptor ligand-dependent manner. The binding is site-specific as Jhdm2a was not detected within the Ucp1 coding region (Fig. 4d, amplicon B) . As expected, the H3K9me2 levels at the Jhdm2a binding site are specifically decreased in response to ISO treatment and this effect is abolished in the Jhdm2a knockdown cells (Fig. 4e) . Notably, enforced overexpression of human JHDM2A in the knockdown cells partially rescued the increased H3K9me2 level in an ISO-dependent manner (Fig. 4e) . Collectively, these results indicate that Jhdm2a expression is regulated by the b-adrenergic signalling pathway and that Jhdm2a contributes to Ucp1 activation by serving as a co-activator in response to b-adrenergic receptor activation.
Previous studies have indicated that Pparc-and Rxra-mediated Ucp1 activation requires the recruitment of co-activators 20 . In addition to removing the repressive H3K9me2 mark at the Ucp1 enhancer, Jhdm2a could contribute to Ucp1 activation by affecting the recruitment of transcription factors and co-activators. To examine this possibility, we analysed the effect of the loss of Jhdm2a on the recruitment of transcription factors (Pparc, Rxra and Atf2) and co-activators (Pgc1a, CBP/p300 and Src1). We found that the binding of Pparc, Rxra and Atf2 to the Ucp1 enhancer is increased in response to ISO treatment (Fig. 4f) . However, the enhanced binding by Pparc and Rxra disappeared in the Jhdm2a knockdown cells (Fig. 4f) . Similar results are also observed for the co-activators (Fig. 4g) . Given that Jhdm2a knockdown does not alter the protein levels of these transcription factors and co-activators ( Supplementary Fig. 10b ), the simplest explanation of the results is that Jhdm2a facilitates their recruitment in response to b-adrenergic stimulation. Our results, together with the previous demonstration that Pparc recruitment to Ucp1 enhancer is blocked in pCip (also known as Ncoa3) and Src1 double knockout BAT 20 , indicate that the binding of transcription factors and coactivators to the Ucp1 enhancer affect one another. Collectively, our data suggest that Jhdm2a contributes to b-adrenergic-stimulated Ucp1 activation by maintaining a low level of H3K9me2 at the Ucp1 enhancer region, and by augmenting the recruitment of Pparc and Rxra and their co-activators to the Ucp1 enhancer element.
In this study we identified Ppara and Ucp1, two of the important genes involved in controlling energy balance, as direct targets of Jhdm2a. Notably, the expression of these two genes, as well as Jhdm2a, is induced after b-adrenergic stimulation 16, 21 (Figs 3e, 4c and Supplementary Fig. 9 ). Thus we propose that Jhdm2a mediates b-adrenergic signalling on the basis of the systemic energy demand. Consistent with this notion, Jhdm2a knockout mice and mice lacking b-adrenergic receptors have similar phenotypes that include defects deficiency impairs the ability of mice to maintain body temperature when exposed to cold. Shown is the body temperature of 12-week-old mice at different times after cold exposure (4 uC). n 5 5 per group; *P , 0.05. in BAT function, cold intolerance, decreased oxygen consumption ( Supplementary Fig. 11 ) and obesity without hyperphagia. Although the Jhdm2a deficiency does not affect metabolic hormone levels ( Supplementary Fig. 12 ), the obesity phenotype supports an important role for Jhdm2a in regulating systemic metabolic control including Ppara and b-adrenergic signalling pathways. Although the entire mechanism underlying the phenotype reported here remains elusive, it is interesting to note that this is a unique mouse model in which a single epigenetic factor deficiency results in obesity.
METHODS SUMMARY
Animal experiments. All animal experiments were performed according to procedures approved by the Institutional Animal Care and Use Committee. Cell culture, viral infection and differentiation. Primary myoblasts were established from neonatal mice as reported 22 . To generate a Jhdm2a knockdown HIB1B cell line, undifferentiated cells were infected with a lentiviral virus expressing an shRNA for Jhdm2a or control. The shRNA sequence for Jhdm2a was 59-GCAGGTGTCACTAGCCTTAAT-39. The differentiation of HIB1B cells was performed as previously described 23 . For the overexpression of the human JHDM2A gene, cells were infected with a retroviral vector expressing Flag-JHDM2A or a control before the cells were subjected to differentiation. 
